A complete application in a minute
Tailored resume and cover letter, ready to send.
IGBMC - Institute of Genetics and Molecular and Cellular Biology in Strasbourg, France, invites applications for a post-doctoral position focused on species-specific mechanisms of ADAT dysfunction in cortical development. The role involves human iPSC- and mouse ESC-derived models to study tRNA modifications and translational control in neurodevelopment.
Applicants should hold a PhD in a relevant field, with experience in iPSC culture and neural differentiation, plus strong communication skills
Post-doctoral Position: Species-specific Mechanisms of ADAT Dysfunction in Cortical Development
IGBMC - Institute of Genetics and Molecular and Cellular Biology
Strasbourg, France
€ 2,940 per month gross
The recruited fellow will join the SpeaDAT project, funded by the French National Research Agency (ANR), on species-specific mechanisms of ADAT dysfunction in brain development, led by Dr. Efil Bayam (CRCN Inserm) within Dr. Juliette Godin's team “Physiological and Pathological Mechanisms of Cortical Development” at IGBMC. The Godin lab is recognized for its expertise in translational control during cortical development.
Chemical modifications on different types of RNA species have emerged as critical posttranscriptional modulators of brain development and function. While transfer RNAs (tRNA) are required for translation in all cells, 77% of the pathogenic mutations in transfer RNA (tRNA) modification enzymes manifest as neurodevelopmental disorders (NDDs) suggesting that developing human brain is particularly sensitive to disrupted tRNA modifications. Recently, the team identified the NDD-associated ADAT complex (ADAT2/3), which catalyzes the conversion of Adenine (A) to Inosine (I) at position 34 of 8 ANN-tRNAs, as a regulator of cortical development and showed the pathogenicity of NDD-relevant ADAT mutations.
Surprisingly, despite the profound impact of ADAT dysfunction in humans, mouse genetic models mimicking the ADAT dysfunction displayed no detectable brain phenotype or tRNA alterations suggesting species-specific vulnerability to defects in ADAT complex.
The postdoctoral researcher will investigate species-specific ADAT functions in progenitors and neurons, and characterize the impact of ADAT dysfunction on tRNAs and translational programs, using human iPSC- and mouse ESC-derived models, including 2D cortical neural stem cells/neurons and 3D cortical organoids carrying ADAT2/ADAT3 pathogenic variants.